RxDoctor Payments Data

Linda Morrison

Acute Care · Clinton Twp, MINPI 1861416067

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.9% of the total across 207 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. Among acute care clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,471in general payments, 2019–2025

Across 207 payments — averaging $21.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$799
  • Johnson & Johnson$796
  • UCB, Inc.$357
  • Novartis$352
  • Sanofi$280
  • Incyte Corporation$217
  • plus $2K from 16 others

What the payments were for

  • Food & beverage$4,28896%
  • Education$1834%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,471 in reported general payments places this provider in the 95th percentile of 567 acute care providers in Michigan.

See all acute care providers in Michigan

Medicare billing

Part B allowed, 2024
$80,868
Medicare patients
304
Services billed
1,599

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metronidazole85$3,778
Clindamycin-Benzoyl PeroxideClindamycin Phos/Benzoyl Perox16$2,878
Pimecrolimus12$2,074
Clobetasol Propionate72$1,832
Fluorouracil35$1,776
Tacrolimus16$1,315
Triamcinolone Acetonide123$1,115
Fluocinolone Acetonide20$610
Ketoconazole44$526
Doxycycline Hyclate30$466
Ammonium Lactate20$362
ValacyclovirValacyclovir Hcl11$347
Desonide18$304
Nystatin-TriamcinoloneNystatin/Triamcinolone Acet21$291
Econazole Nitrate11$260

Paid to pharmacies, not to this prescriber.

Other acute care in Clinton Twp

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →